Interestingly, in breast cancer and glioma, the CacyBP/SIP expression profiles reported by different teams were completely opposite (Nie et al., 2010; Wang et al., 2010; Zhao et al., 2011; Shi et al., 2014). This evidence concerns the gene CACYBP and breast carcinoma.